Cross-fund · 4 holders
AMLX
AMYLYX PHARMACEUTICALS INC
CUSIP 03237H101
4
Tracked holders
$200.9M
Aggregate value
15,209,915
Shares
5
Active funds
Funds holding AMLX
| Fund | Strategy | Period | Value | % of book | Δ shares | Status |
|---|---|---|---|---|---|---|
| BlackRock | Institutional | Q1 2026 | $122.7M | — | -225,595 | -2.5% |
| Vanguard | Institutional | Q4 2025 | $70.1M | — | +531,162 | +10.1% |
| Citadel | Multi-Strategy | Q1 2026 | $6.5M | — | +12,764 | +2.8% |
| Point72FEAT | Multi-Strategy | Q1 2026 | $1.5M | — | -228,465 | -68.2% |
| Millennium | Multi-Strategy | Q1 2026 | — | — | -46,455 | EXITED |
Aggregated from the latest 13F-HR per tracked fund (longs only). QoQ deltas compare against each fund's prior quarterly filing.